News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Syrrx, Inc. Receives Second And Third Success Payments And Announces Completion Of Research Agreement With Biogen Idec, Inc. (Massachusetts) (BIIB)


10/19/2005 5:11:01 PM

Syrrx Inc., a next generation structure-based drug discovery company, today announced the receipt of the second and third success-based milestone payments from Biogen Idec (Nasdaq:BIIB). These payments follow on the heels of the first success payment to Syrrx on May 27th, 2004. The collaboration applies Syrrx's expertise in high-throughput crystallization of proteins across multiple Biogen Idec drug targets. Financial terms were not disclosed.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES